Current HIV Research
Volume 19, 6 Issues, 2021
ISSN: 1873-4251 (Online)
ISSN: 1570-162X (Print)
This journal supports open access
ISSN: 1873-4251 (Online)
ISSN: 1570-162X (Print)
This journal supports open access
Contents
Current HIV Research, Volume 12 - Number 5
Drug Resistance Mutations from Whole Blood Proviral DNA Among Patients on Antiretroviral Drugs in Zimbabwe
, 12(5): 309 - 316Benjamin Chimukangara, Lovemore Gwanzura, Rebecca Mitchell, David Katzenstein and Collen Masimirembwa
DOI: 10.2174/1570162X12666141017100733
Drug Resistance Mutations from Whole Blood Proviral DNA Among Patients on Antiretroviral Drugs in Zimbabwe
Chronic, Highly Productive HIV Infection in Monocytes During Supportive Culture
, 12(5): 317 - 324Manisha Saini and Mary Jane Potash
DOI: 10.2174/1570162X1205141121100659
Chronic, Highly Productive HIV Infection in Monocytes During Supportive Culture
A Novel Integrase Targeting Agent to Explore the Future Prospective of HIV Eradication: Dolutegravir
, 12(5): 325 - 338Bawneet K. Narang, Gurpreet K. Grewal, Subhajit Roy, Jitender Bariwal, Manish K. Gupta and Ravindra K. Rawal
DOI: 10.2174/1570162X12666140807150753
A Novel Integrase Targeting Agent to Explore the Future Prospective of HIV Eradication: Dolutegravir
Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients
, 12(5): 339 - 346S. Bonora, A. Calcagno, O. Vigano, P. Bigliano, L. Marinaro, E. Colella, G. Orofino, L. Trentini, M.C. Tettoni, A. D'Avolio, S. Mercadante, M. Galli, G. Di Perri and S. Rusconi
DOI: 10.2174/1570162X12666140807151616
Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients
2´,3´-Dialdehyde of ATP, ADP, and Adenosine Inhibit HIV-1 Reverse Transcriptase and HIV-1 Replication
, 12(5): 347 - 358Julieta Schachter, Ana Luiza Chaves Valadao, Renato Santana Aguiar, Victor Barreto-de-Souza, Atila Duque Rossi, Pablo Ricardo Arantes, Hugo Verli, Paula Gabriela Quintana, Norton Heise, Amilcar Tanuri, Dumith Chequer Bou-Habib and Pedro Muanis Persechini
DOI: 10.2174/1570162X12666140826105824
2´,3´-Dialdehyde of ATP, ADP, and Adenosine Inhibit HIV-1 Reverse Transcriptase and HIV-1 Replication
Improved Survival with Co-Trimoxazole Prophylaxis among People Living with HIV/AIDS Who Initiated Antiretroviral Treatment in Henan Province, China
, 12(5): 359 - 365Qian Zhu, Liming Wang, Wen Lin, Marc Bulterys, Wenjie Yang, Dingyong Sun, Zhaolin Cui, Jonathan Kaplan, Nora Kleinman, Xiaoyu Wei, Jessica Chung and Zhe Wang
DOI: 10.2174/1570162X1205141121102155
Improved Survival with Co-Trimoxazole Prophylaxis among People Living with HIV/AIDS Who Initiated Antiretroviral Treatment in Henan Province, China
The Combination of Pill Count and Self-Reported Adherence is a Strong Predictor of First-Line ART Failure for Adults in South Africa
, 12(5): 366 - 375Peng Wu, Brent A. Johnson, Jean B. Nachega, Baohua Wu, Claudia E. Ordonez, Anna Q. Hare, Rachel Kearns, Richard Murphy, Henry Sunpath and Vincent C. Marconi
DOI: 10.2174/1570162X1205141121102501
The Combination of Pill Count and Self-Reported Adherence is a Strong Predictor of First-Line ART Failure for Adults in South Africa
Editor-in-Chief
Yuntao Wu
National Center for Biodefense and Infectious Diseases
School of Systems Biology
George Mason University
Manassas, VA
(USA)
Biography
National Center for Biodefense and Infectious Diseases
School of Systems Biology
George Mason University
Manassas, VA
Biography
Biography of Yuntao Wu
Dr. Yuntao Wu is a professor at the National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, USA. He received his Ph.D. from the Department of Microbiology and Immunology at Queen’s University, Kingston, Ontario, Canada, and his postdoctoral training at NIH, Bethesda, Maryland, USA. Dr. Wu studies HIV infection of blood CD4 T cells and macrophages (Science, 2001, 293:1503-6), mainly focusing on the role of chemokine- and HIV-1-mediated G-protein signaling and actin dynamics in HIV infection and pathogenesis (Cell, 2008, 134,782; Science Advances, 2019, 5:1,aat7911). Currently, his lab also studies the mechanisms of PSGL-1 restriction of HIV infection (Nature Microbiology, 2019, 4:813-25).
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Advertisement
Webmaster Contact: info@benthamscience.net